CXCL-10, IL-12 and IL-21 Are Not Immunological Predictors of HBeAg Seroconversion in HIV-1–HBV Coinfection Following HBV-active Antiretroviral Therapy (ART)

Antiviral Therapy - United Kingdom
doi 10.3851/imp2720

Related search